Author:
Petersen Eskild,Hui David S.,Nachega Jean B.,Ntoumi Francine,Goletti Delia,Aklillu Eleni,Sharma Avinash,Nyirenda Thomas,Yeboah-Manu Dorothy,Satta Giovanni,da Costa Christopher,Azhar Esam I.,Bockarie Moses,Al-Abri Seif,McHugh Timothy D.,Rodriguez-Morales Alfonso J.,Varghese George M,Zumla Alimuddin
Funder
University of Aarhus Faculty of Health
Subject
Infectious Diseases,Microbiology (medical),General Medicine
Reference16 articles.
1. TB Alliance-our pipeline. Bedaquiline. https://www.tballiance.org/portfolio/compound/bedaquiline - accessed 3 April, 2023
2. WHO consolidated guidelines on tuberculosis. Module 4: treatment - drug-resistant tuberculosis treatment, 2022 update. https://www.who.int/publications/i/item/9789240063129 - accessed 3 April, 2023
3. MSF demands Johnson & Johnson reduce price of lifesaving TB drug. https://www.msf.org/johnson-johnson-must-halve-price-lifesaving-tb-drug-bedaquiline - accessed 3 April, 2023
4. TB-PRACTECAL Study Collaborators. A 24-Week, All-Oral Regimen for Rifampin-Resistant Tuberculosis;Nyang'wa;N Engl J Med,2022
5. WHO Global Tuberculosis Report 2022. https://www.who.int/teams/global-tuberculosis-programme/tb-reports/global-tuberculosis-report-2022 - accessed 3 April 2023.
Cited by
3 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献